- Home
- ATLX vs TCRX Comparison
ATLX vs TCRX Comparison
Compare ATLX & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLX
- TCRX
- Stock Information
- Founded
- ATLX 2011
- TCRX 2018
- Country
- ATLX Brazil
- TCRX United States
- Employees
- ATLX N/A
- TCRX N/A
- Industry
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- TCRX Biotechnology: Pharmaceutical Preparations
- Sector
- ATLX Industrials
- TCRX Health Care
- Exchange
- ATLX Nasdaq
- TCRX Nasdaq
- Market Cap
- ATLX 90.1M
- TCRX 98.5M
- IPO Year
- ATLX N/A
- TCRX 2021
- Fundamental
- Price
- ATLX $4.07
- TCRX $1.15
- Analyst Decision
- ATLX Strong Buy
- TCRX Strong Buy
- Analyst Count
- ATLX 3
- TCRX 6
- Target Price
- ATLX $33.17
- TCRX $9.83
- AVG Volume (30 Days)
- ATLX 160.0K
- TCRX 473.8K
- Earning Date
- ATLX 05-14-2025
- TCRX 03-05-2025
- Dividend Yield
- ATLX N/A
- TCRX N/A
- EPS Growth
- ATLX N/A
- TCRX N/A
- EPS
- ATLX N/A
- TCRX N/A
- Revenue
- ATLX $748,654.00
- TCRX $2,816,000.00
- Revenue This Year
- ATLX $20,462.24
- TCRX $32.21
- Revenue Next Year
- ATLX $37.63
- TCRX $118.35
- P/E Ratio
- ATLX N/A
- TCRX N/A
- Revenue Growth
- ATLX N/A
- TCRX N/A
- 52 Week Low
- ATLX $4.87
- TCRX $1.20
- 52 Week High
- ATLX $19.37
- TCRX $9.69
- Technical
- Relative Strength Index (RSI)
- ATLX 31.53
- TCRX 26.03
- Support Level
- ATLX $5.37
- TCRX $1.44
- Resistance Level
- ATLX $5.42
- TCRX $1.46
- Average True Range (ATR)
- ATLX 0.36
- TCRX 0.16
- MACD
- ATLX -0.08
- TCRX -0.01
- Stochastic Oscillator
- ATLX 2.00
- TCRX 0.00
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.